Alpha 2 integrin +807 polymorphism in drug-induced gingival overgrowth

J Dent Res. 2005 Dec;84(12):1183-6. doi: 10.1177/154405910508401217.

Abstract

Alpha2 integrin on fibroblasts is reported to play an important role in the induction of drug-induced gingival overgrowth, which is characterized by excessive accumulation of type I collagen in gingival connective tissue. Silent polymorphism 807 T/C within the alpha2 integrin gene is associated with high/low alpha2 integrin expression. The aim of this study was to test the hypothesis that expression of alpha2 integrin 807 T/C polymorphism correlates with drug-induced gingival overgrowth. A case-control study comparing 136 subjects taking calcium channel blockers (72 with vs. 64 without drug-induced gingival overgrowth) demonstrated that the frequency of the +807 C allele was significantly higher in the case group than in the controls (odds ratio, 3.61; 95% confidence interval, 2.14 - 6.10; P < 0.05). The present findings suggest that the alpha2 +807 C allele is one of the genetic risk factors for drug-induced gingival overgrowth.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Calcium Channel Blockers / adverse effects
  • Case-Control Studies
  • Child
  • Cytosine
  • Female
  • Fibroblasts / immunology
  • Gene Frequency
  • Gingival Overgrowth / chemically induced*
  • Gingival Overgrowth / genetics
  • Humans
  • Integrin alpha2 / genetics*
  • Male
  • Middle Aged
  • Polymorphism, Genetic / genetics*
  • Risk Factors
  • Thymine

Substances

  • Calcium Channel Blockers
  • Integrin alpha2
  • Cytosine
  • Thymine